This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

SLx-4090

Nano Terra, Inc.

Drug Names(s): SLx-4090

Description: SLx-4090 is a microsomal triglyceride transfer protein (MTP) inhibitor. It prevents the formation of chylomicrons which are used to transport triglyceride and cholesterol into the systemic circulation. SLx-4090 is selective for enterocytes and is not absorbed into the systemic circulation.

Deal Structure: In April 2011, Nano Terra announced it is acquiring Surface Logix.


SLx-4090 News


Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug